SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-004013
Filing Date
2022-02-11
Accepted
2022-02-11 16:15:32
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 5389
  Complete submission text file 0001493152-22-004013.txt   6816
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 150 E 57TH STREET NEW YORK NY 10022
Business Address
KINGSLEY ALFRED D (Reporting) CIK: 0001229339 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-12830 | Film No.: 22621110